ArticleAlzheimer's research & therapy2022

Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.

Fadi Rofo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.